UPXI (Upexi, Inc. Common Stock)

Insider Trading Activity

Every open-market purchase and sale reported by UPXI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Form 4 Filings
36
most recent
Open-Market Buys
16
code P
Sales
0
code S
Reporting Insiders
6
current holders
UPXI — Recent Form 4 Transactions (latest 2026-07-20)
FiledInsiderRole TypeSharesValue
2026-07-20 Gene Salkind Director A
2026-07-20 Brian Benjamin Rudick Chief Strategy Officer A
2026-07-20 Andrew James Norstrud Chief Financial Officer A
2026-07-20 Lawrence Dugan Director A
2026-07-20 ALLAN MARSHALL Chief Executive Officer A
2025-12-23 ALLAN MARSHALL Chief Executive Officer Buy
2025-12-17 ALLAN MARSHALL Chief Executive Officer MIXED
2025-11-21 Gene Salkind Director Buy
2025-11-21 Andrew James Norstrud Chief Financial Officer A
2025-11-18 Gene Salkind Director Buy
2025-07-30 Gene Salkind Director MIXED
2025-07-24 Andrew James Norstrud Chief Financial Officer A
2025-07-24 Brian Benjamin Rudick CSO A
2025-07-24 Thomas Charles Williams Director A
2025-07-24 ALLAN MARSHALL Chief Executive Officer MIXED
2025-07-24 Lawrence Dugan Director MIXED
2025-04-25 Andrew James Norstrud Chief Financial Officer MIXED
2025-04-25 Lawrence Dugan Director A
2025-04-25 Gene Salkind Director Buy
2025-04-25 ALLAN MARSHALL Chief Executive Officer MIXED
2025-04-25 Thomas Charles Williams Director A
2024-03-18 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2024-03-06 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2023-12-20 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2023-12-07 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2023-12-06 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2023-11-29 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2023-07-07 ALLAN MARSHALL Chief Executive Officer Buy
2023-05-23 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2023-03-20 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2023-01-11 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2022-12-13 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2022-12-05 ALLAN MARSHALL CHIEF EXECUTIVE OFFICER Buy
2022-11-17 Thomas Charles Williams Director A
2022-11-17 Lawrence Dugan Director A
2022-11-17 Gene Salkind Director A
UPXI — Current Insider Holders
InsiderRole Shares HeldValue
Chief Executive Officer 6,046,261
Chief Strategy Officer 1,238,597
Chief Financial Officer 1,049,138
Director 537,500
Director 216,389
Director 100,000
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the UPXI quote page; the site-wide leaderboard is on the insider transactions hub.